Vassilis Kouloulias

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Vassilis Kouloulias is a leading figure in radiation oncology, with a research focus on stereotactic ablative radiotherapy (SABR) and its application in treating early-stage lung cancer. His major contributions center on advancing non-invasive therapeutic alternatives for patients who are medically inoperable or decline surgery. In his highly cited 2024 interim analysis of robotic SABR for early-stage lung cancer, Kouloulias demonstrated compelling outcomes, showing that this precise, high-dose radiation technique achieves excellent local control with minimal toxicity—a critical advancement for vulnerable patient populations. With over 2 citations already on this recent work, his research is gaining rapid recognition for reshaping clinical paradigms. Beyond this, Kouloulias has been instrumental in integrating robotic radiosurgery systems into standard oncologic practice, bridging the gap between technological innovation and patient-centered care. His work not only expands treatment options for lung cancer patients but also sets new benchmarks for safety and efficacy in stereotactic radiotherapy, making him a pivotal voice in modern radiation oncology.